Location: Biologics Development Module
Project Number: 3022-32000-026-000-D
Project Type: In-House Appropriated
Start Date: Jun 22, 2022
End Date: Jun 21, 2027
Objective:
Objective 1. Advance the development of veterinary medical countermeasures to detect, prevent, control, and respond to Foot-and-Mouth Disease (FMD) incursions.
Objective 2. Advance the development of veterinary medical countermeasures to detect, prevent, control, and respond to African Swine Fever (ASF) incursions.
Objective 3. Advance the development of veterinary medical countermeasures to detect, prevent, control, and respond to Vesicular Stomatitis Virus (VSV) incursions.
Objective 4. Advance the development of veterinary medical countermeasures to detect, prevent, control, and respond to Japanese Encephalitis Virus (JEV) incursions.
Objective 5. Advance the development of veterinary medical countermeasures to detect, prevent, control, and respond to Rift Valley Fever (RVF) incursions.
Objective 6. Advance the development of veterinary medical countermeasures to detect, prevent, control, and respond to Henipaviral incursions.
Objective 7. Advance the development of veterinary medical countermeasures to detect, prevent, control, and respond to Crimean-Congo Hemorrhagic Fever Virus (CCHF) incursions.
Objective 8. Advance the development of veterinary medical countermeasures to detect, prevent, control, and respond to new emerging diseases of high consequence to the U.S economy and public health.
Approach:
The mission of the BDM is to provide research, development, testing and evaluation (RDT&E), and technical services necessary to advance through the early development stage, veterinary medical countermeasures (MCM) for a broad array of animal and public health threats. The BDM program at NBAF plays a critical role in bridging the gap to decrease risk for private sector investments in agro- and biodefense MCM development. Mitigating the risk for private sector investments in MCM development for foreign animal diseases is paramount since there is no commercial market for diseases that technically, do not exist in the United States, but pose a significant threat to animal agriculture and public health. Importantly, the BDM directly supports APHIS’s roles and responsibilities related to veterinary public health and food defense associated with emerging and zoonotic high consequence pathogens.
